265 related articles for article (PubMed ID: 3538789)
1. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.
Philippon J; Grob R; Dagreou F; Guggiari M; Rivierez M; Viars P
Acta Neurochir (Wien); 1986; 82(3-4):110-4. PubMed ID: 3538789
[TBL] [Abstract][Full Text] [Related]
2. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
Desbordes JM; Ades PE; Guggiari M
Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
[TBL] [Abstract][Full Text] [Related]
3. Nimodipine in the prevention of ischaemic deficits after aneurysmal subarachnoid haemorrhage. An analysis of recent clinical studies.
Gilsbach JM
Acta Neurochir Suppl (Wien); 1988; 45():41-50. PubMed ID: 3066141
[TBL] [Abstract][Full Text] [Related]
4. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO
J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of vasospasm in aneurysmal meningeal hemorrhage using intravenous nimodipine. Multicenter cooperative study].
Frerebeau P; Janny P; Taquoi G; Besson G; Buchheit F; Childs M; Houtteville JP; Jan M; Jomin M; Pecker J
Neurochirurgie; 1988; 34(6):383-8. PubMed ID: 3070420
[TBL] [Abstract][Full Text] [Related]
6. [Management using nimodipine of cerebral vasospasm secondary to subarachnoid hemorrhage caused by rupture of an intracranial aneurysm].
Maldonado JA; Milchorena G; López-Camacho O; Madrazo I
Arch Invest Med (Mex); 1990; 21(2):179-87. PubMed ID: 2103708
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
Seiler RW; Grolimund P; Zurbruegg HR
Acta Neurochir (Wien); 1987; 85(1-2):7-16. PubMed ID: 2955675
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms.
Jan M; Buchheit F; Tremoulet M
Neurosurgery; 1988 Aug; 23(2):154-7. PubMed ID: 3054619
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine for cerebral vasospasm after subarachnoid hemorrhage.
Med Lett Drugs Ther; 1989 May; 31(792):47-8. PubMed ID: 2654592
[No Abstract] [Full Text] [Related]
10. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.
Allen GS; Ahn HS; Preziosi TJ; Battye R; Boone SC; Boone SC; Chou SN; Kelly DL; Weir BK; Crabbe RA; Lavik PJ; Rosenbloom SB; Dorsey FC; Ingram CR; Mellits DE; Bertsch LA; Boisvert DP; Hundley MB; Johnson RK; Strom JA; Transou CR
N Engl J Med; 1983 Mar; 308(11):619-24. PubMed ID: 6338383
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic treatment of vasospasm with nimodipine in subarachnoid hemorrhage].
Procházka M; Gazdíková K; Cigánek L; Koprdová I
Cas Lek Cesk; 1990 Feb; 129(8):237-9. PubMed ID: 2331740
[TBL] [Abstract][Full Text] [Related]
12. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.
Suzuki S; Sano K; Handa H; Asano T; Tamura A; Yonekawa Y; Ono H; Tachibana N; Hanaoka K
Neurol Res; 1989 Jun; 11(2):79-88. PubMed ID: 2569686
[TBL] [Abstract][Full Text] [Related]
13. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
[TBL] [Abstract][Full Text] [Related]
14. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
15. [Experience with nimodipine treatment of vascular spasm after subarachnoid hemorrhage].
Wroński J; Berny W; Abraszko R; Zub L
Pol Tyg Lek; 1992 May 18-25; 47(20-21):442-4. PubMed ID: 1437762
[TBL] [Abstract][Full Text] [Related]
16. Review of treatment of symptomatic cerebral vasospasm with nimodipine.
Buchheit F; Boyer P
Acta Neurochir Suppl (Wien); 1988; 45():51-5. PubMed ID: 3066142
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage.
Tettenborn D; Dycka J
Stroke; 1990 Dec; 21(12 Suppl):IV85-9. PubMed ID: 2148037
[No Abstract] [Full Text] [Related]
18. A double-blind clinical evaluation of the effect of Nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture.
Saito I; Asano T; Ochiai C; Takakura K; Tamura A; Sano K
Neurol Res; 1983; 5(4):29-47. PubMed ID: 6149485
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
[TBL] [Abstract][Full Text] [Related]
20. Prevention of symptomatic vasospasm after SAH by constant venous infusion of nimodipine.
Grotenhuis JA; Bettag W
Neurol Res; 1986 Dec; 8(4):243-9. PubMed ID: 2880316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
